Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT02435940
- Conditions
- Abetalipoproteinemia, Abnormalities, Multiple, Achromatopsia, +100 more
- Locations
-
- Foundation Fighting Blindness Columbia, Maryland, United States
NCT07085533
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +17 more
- Locations
-
- Renmin Hospital of Wuhan University Wuhan, China
Natural History Study for Achromatopsia
NCT04124185
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- Moorfields Eye Hospital NHS Foundation Trust London, United Kingdom
Gene Therapy for Achromatopsia (CNGB3)
NCT03001310
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- University of Michigan Kellog Eye Centre Ann Arbor, Michigan, United States
- Moorfields Eye Hospital NHS Foundation Trust London, United Kingdom
Gene Therapy for Achromatopsia (CNGA3)
NCT03758404
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- Kellogg Eye Center Ann Arbor, Michigan, United States
- Moorfields Eye Hospital NHS Foundation Trust London, United Kingdom
NCT01846052
- Conditions
- Achromatopsia, Achromatopsia 3, Color Vision Defects, +9 more
- Locations
-
- VitreoRetinal Associates Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Imp Chicago, Illinois, United States
- Casey Eye Institute, Oregon Health & Science University Portland, Oregon, United States
CNTF Implants for CNGB3 Achromatopsia
NCT01648452
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +9 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia
NCT02610582
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- University Hospital Tuebingen, Center for Ophthalmology Tübingen, Germany
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)
NCT02599922
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- VitreoRetinal Associates Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Imp Chicago, Illinois, United States
- Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
NCT02935517
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- VitreoRetinal Associates Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
- Cincinnati Eye Institute Cincinnati, Ohio, United States